Published in Acta Pathol Microbiol Scand A on January 01, 1971
Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc (1987) 4.21
FK506 suppression of heart and liver allograft rejection. II: The induction of graft acceptance in rats. Transplantation (1990) 2.13
Preformed lymphocytotoxic antibodies: the effects of class, titer and specificity on liver vs. heart allografts. Hepatology (1992) 1.18
Accumulation of hyaluronan (hyaluronic acid) in myocardial interstitial tissue parallels development of transplantation edema in heart allografts in rats. J Clin Invest (1990) 0.89
Further study of anti-ICOS immunotherapy for rat cardiac allograft rejection. Surg Today (2008) 0.88
Clonal deletion as the mechanism of abrogation of immunological memory following liver grafting in rats. Immunology (1985) 0.87
In situ detection of tissue factor within the coronary intima in rat cardiac allograft vasculopathy. Am J Pathol (1999) 0.86
Nrf2 is crucial to graft survival in a rodent model of heart transplantation. Oxid Med Cell Longev (2013) 0.82
Transfer of specific immunosuppression of graft rejection using lymph from tolerant liver-grafted rats. Immunology (1985) 0.81
Murine cervical heart transplantation model using a modified cuff technique. J Vis Exp (2014) 0.79
Stabilizing endothelium of donor hearts with fusogenic liposomes reduces myocardial injury and dysfunction. J Surg Res (2012) 0.78
Netrin-1 attenuates cardiac ischemia reperfusion injury and generates alternatively activated macrophages. Inflammation (2014) 0.78
Novel cuff design to facilitate anastomosis of small vessels during cervical heterotopic heart transplantation in rats. Comp Med (2014) 0.78
Inhibition of warm ischemic injury to rat liver, pancreas, and heart grafts by controlling the nutritional status of both donor and recipient. Surg Today (1997) 0.77
Functional evaluation of rat hearts transplanted after preservation in a high-pressure gaseous mixture of carbon monoxide and oxygen. Sci Rep (2016) 0.77
A new simplified volume-loaded heterotopic rabbit heart transplant model with improved techniques and a standard operating procedure. J Thorac Dis (2015) 0.75
Long-term residence of a graft is an insufficient stimulus for the induction of tolerance. Investigating the role of cyclosporine in class I-disparate heart grafts in the rat. J Exp Med (1988) 0.75
Preformed antibodies in sensitized recipients: effect of immunoglobulin titer, class, and specificity on liver and heart allografts. Transplant Proc (1993) 0.75
Effect of miR-146a and miR-155 on cardiac xenotransplantation. Exp Ther Med (2016) 0.75
Proteins released from Mycobacterium tuberculosis during growth. Infect Immun (1991) 3.69
T-cell proliferative response to antigens secreted by Mycobacterium tuberculosis. Infect Immun (1991) 2.43
Specificity of a protective memory immune response against Mycobacterium tuberculosis. Infect Immun (1993) 2.27
Immunity against tetanus and effect of revaccination 25-30 years after primary vaccination. Lancet (1984) 2.16
Identification of immunodominant antigens during infection with Mycobacterium tuberculosis. Scand J Immunol (1992) 2.05
Enhanced expression of beta2-microglobulin and HLA antigens on human lymphoid cells by interferon. Proc Natl Acad Sci U S A (1978) 1.98
Allergenic and blastogenic reactivity of three antigens from Mycobacterium tuberculosis in sensitized guinea pigs. Infect Immun (1987) 1.96
Antibody responses against Mycobacterium tuberculosis in 11 strains of inbred mice: novel monoclonal antibody specificities generated by fusions, using spleens from BALB.B10 and CBA/J mice. Infect Immun (1988) 1.70
Cloning, partial sequence, expression, and antigenic analysis of the filamentous hemagglutinin gene of Bordetella pertussis. Infect Immun (1990) 1.66
Regulatory effect of interferon on T cells in vitro. J Immunol (1976) 1.62
Immunity against diphtheria 25-30 years after primary vaccination in childhood. Lancet (1985) 1.54
In vitro stimulation of human lymphocytes by purified cytomegalovirus. Intervirology (1977) 1.45
Monoclonal antibodies produced in BALB.B10 mice define new antigenic determinants in culture filtrate preparations of Mycobacterium tuberculosis. J Clin Microbiol (1988) 1.44
Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adults. Vaccine (1999) 1.33
Simultaneous electroelution of whole SDS-polyacrylamide gels for the direct cellular analysis of complex protein mixtures. J Immunol Methods (1993) 1.32
ELISA for the routine determination of antitoxic immunity to tetanus. J Biol Stand (1986) 1.32
Evaluation of vaccination requirements to secure continuous antitoxin immunity to tetanus. Vaccine (1987) 1.25
Modification of the ELISA for the estimation of tetanus antitoxin in human sera. J Biol Stand (1987) 1.23
Proliferative responses and gamma interferon and tumor necrosis factor production by lymphocytes isolated from tracheobroncheal lymph nodes and spleen of mice aerosol infected with Bordetella pertussis. Infect Immun (1992) 1.16
Studies on the differentiation of T lymphocytes in sheep. I. Recognition of a sheep T-lymphocyte differentiation antigen by a monoclonal antibody T-80. Immunology (1983) 1.14
The migration of lymphocytes in the fetal lamb. Eur J Immunol (1979) 1.12
Immunity against diphtheria and tetanus in the age group 30-70 years. Scand J Infect Dis (1988) 1.11
Cell-mediated cytotoxicity to herpes-infected cells in humans: dependence on antibodies. Infect Immun (1977) 1.11
Nucleophosmin is a novel Bax chaperone that regulates apoptotic cell death. Oncogene (2006) 1.09
Bordetella pertussis and chronic cough in adults. Clin Infect Dis (1999) 1.06
The interaction between pertussis toxin and 10 monoclonal antibodies. Acta Pathol Microbiol Immunol Scand C (1987) 1.00
Immunodominant domains present on the Bordetella pertussis vaccine component filamentous hemagglutinin. J Infect Dis (1997) 0.99
Natural killer cell activity correlates with the amount of beta 2-microglobulin on human peripheral blood lymphocytes. Cell Immunol (1982) 0.96
The actions of interferon are potentiated at elevated temperature. Nature (1978) 0.96
T-cell recirculation in the sheep: migratory properties of cells from lymph nodes. Immunology (1982) 0.96
Lymphocyte recirculation in the sheep fetus. Ciba Found Symp (1980) 0.96
Affinity purification, biological characterization and serological evaluation of defined antigens from Mycobacterium tuberculosis. Trop Med Parasitol (1990) 0.96
Fate of tumor cells injected into left ventricle of heart in BALB/c mice: role of natural killer cells. J Natl Cancer Inst (1988) 0.95
Intranasal booster vaccination against diphtheria and tetanus in man. Vaccine (1997) 0.95
Bordetella pertussis diagnosed by polymerase chain reaction. APMIS (1994) 0.94
Susceptibility to diphtheria in populations vaccinated before and after elimination of indigenous diphtheria in Denmark. A comparative study of antitoxic immunity. Acta Pathol Microbiol Immunol Scand C (1987) 0.93
Lymphocyte proliferative responses and the occurrence of dermatophilosis in cattle naturally infested with Amblyomma variegatum. Vet Parasitol (1994) 0.93
Collection of lymph from single lymph nodes and the intestines of fetal lambs in utero. Int Arch Allergy Appl Immunol (1979) 0.92
The fall-off in serum concentration of tetanus antitoxin after primary and booster vaccination. Acta Pathol Microbiol Immunol Scand C (1986) 0.92
Booster vaccination against diphtheria and tetanus in man. Comparison of three different vaccine formulations--III. Vaccine (1996) 0.92
Reversible opening of the blood-brain barrier by anti-bacterial antibodies. Proc Natl Acad Sci U S A (1993) 0.91
Immunity against diphtheria and tetanus in human immunodeficiency virus-infected Danish men born 1950-59. APMIS (1992) 0.91
The Isopaque-Ficoll method re-evaluated: selective loss of autologous rosette-forming lymphocytes during isolation of mononuclear cells from human peripheral blood. Scand J Immunol (1980) 0.90
Proliferative responses to purified and fractionated Bordetella pertussis antigens in mice immunized with whole-cell pertussis vaccine. Vaccine (1993) 0.90
Double-antibody sandwich enzyme-linked immunosorbent assay for rapid detection of toxin-producing Corynebacterium diphtheriae. J Clin Microbiol (1987) 0.90
Improved ELISA for determination of anti-diphtheria and/or anti-tetanus antitoxin antibodies in sera. APMIS (1997) 0.89
Simultaneous quantitation of diphtheria and tetanus antibodies by double antigen, time-resolved fluorescence immunoassay. J Immunol Methods (1996) 0.89
An improved technique for obtaining E rosettes with human lymphocytes and its use for B cell purification. J Immunol Methods (1976) 0.89
The effect of interferon on lymphocyte-mediated effector cell functions: selective enhancement of natural killer cells. Cell Immunol (1979) 0.89
Increased expression of beta 2-microglobulin and histocompatibility antigens on human lymphoid cells induced by interferon. J Interferon Res (1981) 0.89
The cell mediated and humoral immune response to vaccination with acellular and whole cell pertussis vaccine in adult humans. FEMS Microbiol Immunol (1991) 0.88
Effector cell involved in cell-mediated cytotoxicity to cells infected with herpes simplex virus type 1. Infect Immun (1977) 0.88
Preclinical studies on a recombinant group B meningococcal porin as a carrier for a novel Haemophilus influenzae type b conjugate vaccine. Vaccine (1998) 0.88
Lymphocytic 2',5'-oligoadenylate synthetase activity increases prior to the appearance of neutralizing antibodies and immunoglobulin M and immunoglobulin G antibodies after primary and secondary immunization with yellow fever vaccine. Clin Diagn Lab Immunol (1995) 0.87
Fall-off in immunity following diphtheria revaccination--an 8 year follow-up study. APMIS (1996) 0.86
Immunity to tetanus and diphtheria in rural Africa. Am J Trop Med Hyg (1997) 0.86
Two small lymphocyte subpopulations in human peripheral blood. I. Purification and surface marker profiles. Int Arch Allergy Appl Immunol (1978) 0.86
Is the acute encephalopathy test in mice suited for control of pertussis vaccines? Dev Biol Stand (1985) 0.86
Corticosteroids decrease the expression of beta 2-microglobulin and histocompatibility antigens on human peripheral blood lymphocytes in vitro. Clin Exp Immunol (1981) 0.85
Revaccination of adults against diphtheria. II: Combined diphtheria and tetanus revaccination with different doses of diphtheria toxoid 20 years after primary vaccination. Acta Pathol Microbiol Immunol Scand C (1986) 0.85
Characterisation of ovine Bordetella parapertussis isolates by analysis of specific endotoxin (lipopolysaccharide) epitopes, filamentous haemagglutinin production, cellular fatty acid composition and antibiotic sensitivity. FEMS Microbiol Lett (1995) 0.84
Stimulation of human lymphocytes by cytomegalovirions and dense bodies. Med Microbiol Immunol (1978) 0.83
Occurrence of cytotoxic antibodies during pregnancy. Vox Sang (1971) 0.82
Immunogenicity and safety of a tetravalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine. Scand J Infect Dis (1999) 0.82
A paraffin embedding method in kidney immunofluorescent studies. Acta Pathol Microbiol Scand B Microbiol Immunol (1970) 0.82
Proliferative response to seven affinity purified mycobacterial antigens in eight strains of inbred mice. Int J Lepr Other Mycobact Dis (1991) 0.82
13 native human interferon-alpha species assessed for immunoregulatory properties. J Interferon Res (1983) 0.82
Intranasal administration of diphtheria toxoid. Selecting antibody isotypes using formulations having various lipophilic characteristics. Vaccine (1995) 0.82
Identification of human T-cell epitopes on the S4 subunit of pertussis toxin. Infect Immun (1992) 0.82
Multivalent pneumococcal capsular polysaccharide conjugate vaccines employing genetically detoxified pneumolysin as a carrier protein. Vaccine (1998) 0.81
Improved vaccination response during ranitidine treatment, and increased plasma histamine concentrations, in patients with B cell chronic lymphocytic leukemia. Leukemia (1995) 0.81
Human leucocyte interferon: analysis of effect on MLC and effector cell generation. Scand J Immunol (1979) 0.81
Postimmunization activity of oligoadenylate synthetase in peripheral blood lymphocytes from healthy individuals. J Clin Lab Immunol (1989) 0.81
Lymphocyte-mediated cytotoxicity in humans during revaccination with vaccinia virus. Infect Immun (1978) 0.80
Immune response to other agents of calves persistently infected with bovine virus diarrhoea virus (BVDV). Acta Vet Scand (1993) 0.80
Cell mediated lympholysis in man. A case of "non relevant" killing of third party persons. Tissue Antigens (1974) 0.80
Booster vaccination against diphtheria and tetanus in man. Comparison of calcium phosphate and aluminium hydroxide as adjuvants--II. Vaccine (1995) 0.80
Purification of human interferon by antibody affinity chromatography, using highly absorbed anti-interferon. Scand J Immunol (1978) 0.80
The complete purification of human leucocyte interferon. Scand J Immunol (1980) 0.80
Modification of lymphocyte response to phytomitogens by polycations and polyanions. Experientia (1978) 0.80
Culture phenotypes and molecular characterization of Mycobacterium avium subsp. paratuberculosis isolates from small ruminants. Res Vet Sci (2013) 0.79
Kidney transplantation in the rabbit. A new method. Acta Pathol Microbiol Scand A (1970) 0.79
Revaccination of adults against diphtheria. I: Responses and reactions to different doses of diphtheria toxoid in 30-70-year-old persons with low serum antitoxin levels. Acta Pathol Microbiol Immunol Scand C (1986) 0.79
Elevated serum Cu in Hodgkin's disease and inhibitory effects of ceruloplasmin on lymphocyte response in vitro. Eur J Cancer (1980) 0.79
Immunity against tetanus and response to revaccination in surgical patients more than 50 years of age. Surg Gynecol Obstet (1987) 0.79
Identification of murine T-cell epitopes on the S4 subunit of pertussis toxin. Infect Immun (1993) 0.79
In vivo cell-mediated immunity and vaccination response following prolonged, intense exercise. Med Sci Sports Exerc (1997) 0.79
Determination of tetanus and diphtheria antitoxin content in dried samples of capillary blood: a convenient method applied to infants. Scand J Infect Dis (1987) 0.79
Epidemiology of tetanus in Denmark 1920-1982. Scand J Infect Dis (1987) 0.79
Interferon-induced augmentation of cytotoxic killer cell generation in mixed lymphocyte cultures: analysis of the effector cell product. Scand J Immunol (1981) 0.78
Studies on postpartum rats accepting heart allografts: evidence for immunological enhancement. Transplantation (1972) 0.78
Cytotoxic antibodies and accellerated rejection of the transplanted rabbit heart. The effect of presensitization. Acta Pathol Microbiol Scand A (1971) 0.78
Selective effects of alpha interferon on human T-lymphocyte subsets during mixed lymphocyte cultures. Scand J Immunol (1983) 0.78
The effect of conjugation on immunogenicity and potency of protein carriers of polyribosylribitol phosphate (PRP) conjugated vaccines in the mouse model. APMIS (1998) 0.78
WHO guidelines for the production and control of the acellular pertussis component of monovalent or combined vaccines. Biologicals (1998) 0.77
Identification of B-cell epitopes on the S4 subunit of pertussis toxin. Infect Immun (1993) 0.77
Human lymphocyte and mouse erythrocyte rosettes. Optimization of the assay. Scand J Haematol (1981) 0.77
The generation of guinea pig T-cell lines reactive to antigens from Mycobacterium tuberculosis. Selected lines induce erythematous skin reactions. Scand J Immunol (1989) 0.77